The Clinical Core of the Johns Hopkins Alzheimer s Disease Research Center (ADRC) s a shared resource available to investigators at Johns Hopkins and elsewhere interested in or conducting clinical or translational research in the cognitive disorders field. Working closely with the Education Core, the Data Core, and Neuropathology Core, the Clinical Core strives to: (1) support funded investigators at Johns Hopkins with key resources, (2) further the research mission of the JHADRC, and (3) promote new and expanded research activities locally and nationally in this complex field. The Core supports the full range of research related activities unique to the field and advises investigators on study design, recruitment, clinical measurement, clinical operations, bio-specimen management (collection, processing, storage), and autopsy research. Central to the Clinical Core s mission is the recruitment and longitudinal characterization of a range of diverse research subjects who participate in investigations associated with the JHADRC. A priority is given to maintaining the current level of representation of minorities, African-Americans in particular, among the study subjects.
The specific aims of the Clinical Core are to: (1) recruit and follow a diverse cohort of subjects, (2) perform annual standardized medical, neurologic, psychiatric and neuropsychological evaluations on all subjects in the Core, (3) provide well-characterized subjects to IRB-approved research associated with the JHADRC, (4) maintain a high autopsy rate (>70% of deceased autopsied), (5) assist the Neuropathology Core in collecting plasma, serum, and DNA from normal controls, individuals with MCI, and cases of AD and related dementias, and to complete APOE genotyping on all subjects, (6) participate in collaborative research with other ADRCs and ADCs and the ADCS, including multi-center therapeutic clinical trials related to AD, and (7) share clinical data with the National Alzheimer Coordinating Center (NACC), and with other investigators conducting multi-center analyses of clinical data. The Clinical Core has contributed importantly to the many innovative findings concerning AD and related disorders emerging from the JHADRC. Additionally, through efforts of our Core, a number of successful novel clinical trials have been reported and are likely to lead to improved care for patients in the coming years.

Public Health Relevance

CLINICAL CORE CORE B: PROJECT NARRATIVE The Johns Hopkins Alzheimer s Disease Research Center is an integrated program aimed at finding improved treatments for patients with Alzheimer disease and related disorders. Complimentary activities within the center include clinical and basic research studies that incorporate state-of-the art methodologies, and contribute significantly to national programs. We are dedicated to training the next generation of investigators and to reaching out to the community to improve understanding about these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-35
Application #
9462692
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
35
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Bouhrara, Mustapha; Reiter, David A; Bergeron, Christopher M et al. (2018) Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement 14:998-1004
Xiong, Yulan; Neifert, Stewart; Karuppagounder, Senthilkumar S et al. (2018) Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A 115:1635-1640
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Wong, Dean F; Comley, Robert A; Kuwabara, Hiroto et al. (2018) Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects. J Nucl Med 59:1869-1876
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Varma, Vijay R; Oommen, Anup M; Varma, Sudhir et al. (2018) Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med 15:e1002482
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Soldan, Anja; Pettigrew, Corinne; Albert, Marilyn (2018) Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. Psychiatr Clin North Am 41:65-77
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Bermudez, Camilo; Plassard, Andrew J; Davis, Taylor L et al. (2018) Learning Implicit Brain MRI Manifolds with Deep Learning. Proc SPIE Int Soc Opt Eng 10574:

Showing the most recent 10 out of 830 publications